Maria-Christina Zennaro
Zennaro, Maria-Christina
VIAF ID: 197956038 (Personal)
Permalink: http://viaf.org/viaf/197956038
Preferred Forms
- 100 0 _ ‡a Maria-Christina Zennaro
- 100 1 _ ‡a Zennaro, Maria-Christina
- 100 1 _ ‡a Zennaro, Maria-Christina
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
30 YEARS OF THE MINERALOCORTICOID RECEPTOR: The scientific impact of cloning the mineralocorticoid receptor: 30 years on | |
Activation of the Hypothalamic-Pituitary-Adrenal Axis in Adults With Mineralocorticoid Receptor Haploinsufficiency | |
Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism | |
Aldosterone-Producing Adenoma Formation in the Adrenal Cortex Involves Expression of Stem/Progenitor Cell Markers | |
Aldosterone resistance: structural and functional considerations and new perspectives | |
Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism | |
Asymptomatic myocardial ischemic disease in antiphospholipid syndrome: A controlled cardiac MRI study | |
Autosomal Dominant Pseudohypoaldosteronism Type 1: Mechanisms, Evidence for Neonatal Lethality, and Phenotypic Expression in Adults | |
Bilateral Idiopathic Adrenal Hyperplasia: Genetics and Beyond. | |
CACNA1H Mutations Are Associated With Different Forms of Primary Aldosteronism | |
Cardiovascular effects of aldosterone: insight from adult carriers of mineralocorticoid receptor mutations | |
Characterization of the development of aldosterone-producing adenomas using somatic genomics approaches. | |
A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. | |
Corticosteroid receptors and aging | |
Diagnostic moléculaire du pseudohypoaldostéronisme de type I : mise en place au laboratoire de génétique et étude des résultats obtenus chez 36 patients | |
Diastrophic dysplasia sulfate transporter (SLC26A2) is expressed in the adrenal cortex and regulates aldosterone secretion | |
Dkk3 is a component of the genetic circuitry regulating aldosterone biosynthesis in the adrenal cortex | |
Functional histopathological markers of aldosterone producing adenoma and somatic KCNJ5 mutations | |
A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism. | |
Genetics of mineralocorticoid excess: an update for clinicians | |
Hibernoma development in transgenic mice identifies brown adipose tissue as a novel target of aldosterone action. | |
HTA sous itraconazole : une nouvelle cause d’HTA iatrogène | |
Identification de nouveaux gènes impliqués dans le pseudohypoaldosteronisme de type 1 | |
Identification of new treatment and diagnostic options in Primary Aldosteronism. | |
Increased arterial stiffness in systemic lupus erythematosus (SLE) patients at low risk for cardiovascular disease: a cross-sectional controlled study. | |
Inherited forms of mineralocorticoid hypertension | |
KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism | |
Mast cell hyperplasia is associated with aldosterone hypersecretion in a subset of aldosterone-producing adenomas | |
Mécanisme d'action des vésicules extracellulaires sécrétées par des progéniteurs cardiovasculaires dans le traitement de l'insuffisance cardiaque. | |
Mineralocorticoid effector mechanism in preeclampsia | |
Mineralocorticoid receptor p.I180V polymorphism: association with body mass index and LDL-cholesterol levels | |
Modification of chondrocyte phenotype in growth plate and articular cartilage : from physiology to pathology. | |
Molecular characterization of the mineralocorticoid receptor in pseudohypoaldosteronism. | |
The molecular pathogenesis of GIP-dependent adrenal hyperplasia and invasive pituitary adenomas. | |
A network perspective on metabolic inconsistency | |
A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action | |
Paracrine control of steroidogenesis by serotonin in adrenocortical neoplasms. | |
Pathogénie moléculaire de l'hyperplasie surrénalienne GIP-dépendante et du comportement invasif des adénomes hypophysaires | |
Physiology and Pathophysiology of the chloride transport in renal collecting duct : characterization of a mouse model of distal renal tubular acidosis and Study of the mechanisms of regulation of ClC-Kb/Barttin channel. | |
Primary Aldosteronism Takes (KCNJ)Five! | |
Progesterone increase counteracts aldosterone action in a pregnant woman with primary aldosteronism | |
Pseudohypoaldosteronism: evaluation of type I receptors by radioreceptor assay and by antireceptor antibodies. | |
Pseudohypoaldosteronism type 1: the index case revisited | |
Le pseudohypoaldostéronisme de type 1 de forme généralisée : données cliniques, biologiques et génétiques sur une série de 33 cas | |
Regulation of aldosterone receptors in hypertension | |
Rôle de la voie Wnt/ßcaténine dans la physiopathologie de la cortico-surrénale | |
The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism | |
SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook | |
Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension | |
Structure, expression and regulation of the human mineralocorticoid receptor gene. | |
Syndromes of glucocorticoid and mineralocorticoid resistance. | |
Task3 Potassium Channel Gene Invalidation Causes Low Renin and Salt-Sensitive Arterial Hypertension | |
WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production |